BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/28/2023 12:59:29 PM | Browse: 214 | Download: 587
 |
Received |
|
2022-11-20 11:31 |
|
Peer-Review Started |
|
2022-11-20 11:32 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-02 21:29 |
|
Revised |
|
2023-01-12 18:18 |
|
Second Decision |
|
2023-03-06 03:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-03-14 18:41 |
|
Articles in Press |
|
2023-03-14 18:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-20 11:56 |
|
Publish the Manuscript Online |
|
2023-03-28 12:59 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Autoimmune liver diseases and SARS-CoV-2
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Costantino Sgamato, Alba Rocco, Debora Compare, Stefano Minieri, Stefano Andrea Marchitto, Simone Maurea and Gerardo Nardone |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alba Rocco, PhD, Doctor, Doctor, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via S. Pansini, 5, Naples 80131, Italy. a.rocco@unina.it |
| Key Words |
Autoimmune liver disease; SARS-CoV-2; COVID-19; COVID-19 vaccine; Autoimmune hepatitis |
| Core Tip |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a possible trigger of autoimmunity. Patients with autoimmune liver diseases (AILDs) were considered at higher risk of SARS-CoV-2 infection and more susceptible to severe coronavirus disease 2019 (COVID-19) due to genetic background and immunosuppressive treatments. Case reports documenting autoimmune hepatitis-like syndromes after the COVID vaccine started to emerge, raising worries about a possible risk of unwanted immunological side effects, especially in individuals predisposed to autoimmune disorders. We herein discuss the consequences of SARS-CoV-2 infection in patients with AILDs and the role of the vaccines in inducing liver autoimmunity. |
| Publish Date |
2023-03-28 12:59 |
| Citation |
Sgamato C, Rocco A, Compare D, Minieri S, Marchitto SA, Maurea S, Nardone G. Autoimmune liver diseases and SARS-CoV-2. World J Gastroenterol 2023; 29(12): 1838-1851 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i12/1838.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i12.1838 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
